Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Generic Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials |
| BNF code | 1404000ATAABKBK |
| Virtual Therapeutic Moiety | COVID-19 vaccine |
| Basis of preferred name | Other |
| Prescribing status | Never Valid To Prescribe As A VMP |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Andusomeran |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 100.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | dispersioninjection.intramuscular |
| Dose Form | |
| Formulation | Dispersion for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials (Moderna, Inc) | |
| Virtual Medicinal Product Packs | |
| Generic Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials 2.5 ml | |
| Generic Spikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials 25 ml | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.